Location History:
- Lafayette, IN (US) (2007)
- Laytonville, MD (US) (2010)
- Laytonsville, MD (US) (2005 - 2023)
Company Filing History:
7 out of 2,656 
5 out of 1,860 
3 out of 11 
Years Active: 2005-2023
Title: The Innovations of Michael Scott Kinch
Introduction
Michael Scott Kinch, hailing from Laytonsville, MD, is a distinguished inventor with an impressive portfolio of 19 patents. His contributions primarily focus on the innovative realms of immunology and cancer treatment. Kinch's work is notable for its potential impact on therapies for cancers that overexpress EphA2, particularly renal cell carcinoma.
Latest Patents
Among his latest advancements, Kinch has developed patents related to EphA2 T-cell epitope agonists. These patents detail the specific peptides derived from human EphA2 protein, which contain one or more T-cell epitopes and conservative derivatives. The innovative EphA2 T-cell epitopes hold substantial clinical utility as they can be utilized in assays, such as ELISPOT assays, to assess and quantify a patient's immune response to EphA2. Additionally, these epitopes play a crucial role in modulating a patient's immune reactivity to EphA2, paving the way for novel treatments for cancers like renal cell carcinoma (RCC). Furthermore, Kinch's research includes methods to vaccinate patients against EphA2 using both in vivo and ex vivo approaches.
Career Highlights
Michael Scott Kinch has collaborated with prominent institutions, including the Purdue Research Foundation and the University of Pittsburgh - of the Commonwealth System of Higher Education. His work within these esteemed organizations has significantly contributed to the advancement of cancer immunotherapy.
Collaborations
Kinch has worked alongside notable colleagues, including Walter J. Storkus and Nicole D. Zantek. Their combined expertise has advanced the research and development of innovative therapies targeting EphA2, demonstrating the power of collaboration in scientific advancements.
Conclusion
Through his inventions and patents, Michael Scott Kinch is making strides in the fight against cancer. His work on EphA2 T-cell epitopes represents a promising frontier in immunotherapy, showcasing the potential for innovative treatments that can improve patient outcomes. With his numerous patents and collaborative efforts, Kinch continues to be a pivotal figure in the landscape of medical innovation.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.